May 9, 2020 10:33 AM EDTUpdated May 12, 04:08 AM
Coronavirus

Covid-19 roundup: Charles Riv­er gets slammed by the pan­dem­ic; For­mer Sanofi R&D chief Elias Zer­houni heads a list of can­di­dates for Covid-19 drug czar; Feds try to sort out remde­sivir dis­tri­b­u­tion mess

John Carroll

Editor & Founder

Natalie Grover

Reporter

Jason Mast

Editor

Charles Riv­er Labs $CRL, the big CRO that spe­cial­izes in pre­clin­i­cal re­search pro­grams, cruised through Q1 with a boom­ing bio­phar­ma in­dus­try feed­ing its op­er­a­tions with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times